Gene signatures in U-BIOPRED severe asthma for molecular phenotyping and precision medicine: time for clinical use

References

• Thamrin C, Frey U, Kaminsky DA, et al. Systems biology and clinical practice in Respiratory medicine. The twain shall meet. Am J Respir Crit Care Med. 2016 Nov 1;194(9):1053–1061. doi: 10.1164/rccm.201511-2288PP
   PubMed Web of Science ®Google Scholar
• Chung KF. New treatments for severe treatment-resistant asthma: targeting the right patient. Lancet Respir Med. 2013;1(8):639–652. doi: 10.1016/S2213-2600(13)70128-0
   PubMed Web of Science ®Google Scholar
• Chung KF, Adcock IM. Precision medicine for the discovery of treatable mechanisms in severe asthma. Allergy. 2019 Sep;74(9):1649–1659. doi: 10.1111/all.13771
   PubMed Web of Science ®Google Scholar
• Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008 Sep 20;372(9643):1107–1119. doi: 10.1016/S0140-6736(08)61452-X
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Koppelman GH, Taichman DB. Biologic therapies for severe asthma. N Engl J Med. 2022 Jan 13;386(2):157–171. doi: 10.1056/NEJMra2032506
   PubMed Web of Science ®Google Scholar
• Li CX, Wheelock CE, Sköld CM, et al. Integration of multi-omics datasets enables molecular classification of COPD. Eur Respir J. 2018 May;51(5):1701930. doi: 10.1183/13993003.01930-2017
   PubMed Web of Science ®Google Scholar
• Wheelock CE, Goss VM, Balgoma D, et al. Application of ‘omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J. 2013 Sep;42(3):802–825. doi: 10.1183/09031936.00078812
   PubMed Web of Science ®Google Scholar
• De Meulder B, Lefaudeux D, Bansal A, et al. A computational framework for complex disease stratification from multiple large-scale datasets. BMC Syst Biol. 2018;12(1):60. doi: 10.1186/s12918-018-0556-z
   PubMedGoogle Scholar
• Itadani H, Mizuarai S, Kotani H. Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation. Curr Genomics. 2008;9(5):349–360. doi: 10.2174/138920208785133235
   PubMed Web of Science ®Google Scholar
• Mallik S, Zhao Z. Identification of gene signatures from RNA-seq data using Pareto-optimal cluster algorithm. BMC Syst Biol. 2018 Dec 21;12(Suppl 8):126. doi: 10.1186/s12918-018-0650-2
   PubMedGoogle Scholar
• Sikkema L, Ramírez-Suástegui C, Strobl DC, et al. An integrated cell atlas of the lung in health and disease. Nat Med. 2023 Jun;29(6):1563–1577. doi: 10.1038/s41591-023-02327-2
   PubMed Web of Science ®Google Scholar
• Vieira Braga FA, Kar G, Berg M, et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med. 2019 Jul;25(7):1153–1163. doi: 10.1038/s41591-019-0468-5
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Wang C, Zhou Y, et al. Gene set enrichment analysis made simple. Stat Methods Med Res. 2009 Dec;18(6):565–575. doi: 10.1177/0962280209351908
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. 2010 Jan 1;26(1):139–140. doi: 10.1093/bioinformatics/btp616
   Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545–15550. doi: 10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14(1):7. doi: 10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015 Nov;46(5):1308–1321. doi: 10.1183/13993003.00779-2015
   PubMed Web of Science ®Google Scholar
• Kuo CS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J. 2017;49(2):443–455. doi: 10.1183/13993003.02135-2016
   Web of Science ®Google Scholar
• Schofield JPR, Burg D, Nicholas B, et al. Stratification of asthma phenotypes by airway proteomic signatures IT is tehre. J Allergy Clin Immunol. 2019;14(10):123.
   Google Scholar
• Kuo CS, Pavlidis S, Loza M, et al. A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED. Am J Respir Crit Care Med. 2017 Feb 15;195(4):443–455. doi: 10.1164/rccm.201512-2452OC
   PubMed Web of Science ®Google Scholar
• Pavlidis S, Takahashi K, Ng Kee Kwong F, et al. “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J. 2019 Jan;53(1):1800938. doi: 10.1183/13993003.00938-2018
   PubMed Web of Science ®Google Scholar
• Hekking PP, Loza MJ, Pavlidis S, et al. Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J Allergy Clin Immunol. 2018 Apr;141(4):1280–1290. doi: 10.1016/j.jaci.2017.06.037
   PubMed Web of Science ®Google Scholar
• Hekking PP, Loza MJ, Pavlidis S, et al. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017 Sep;50(3):1602298. doi: 10.1183/13993003.02298-2016
   PubMed Web of Science ®Google Scholar
• Hoda U, Pavlidis S, Bansal AT, et al. Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort. Clin Transl Med. 2022 Apr;12(4):e816. doi: 10.1002/ctm2.816
   PubMed Web of Science ®Google Scholar
• Perotin JM, Schofield JPR, Wilson SJ, et al. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux. Eur Respir J. 2019 Jun;53(6):1900453. doi: 10.1183/13993003.00453-2019
   PubMed Web of Science ®Google Scholar
• Takahashi K, Pavlidis S, Ng Kee Kwong F, et al. Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis. Eur Respir J. 2018;51(5):1280–1290. doi: 10.1183/13993003.02173-2017
   Web of Science ®Google Scholar
• Jevnikar Z, Ostling J, Ax E, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2019;143(2):577–590. doi: 10.1016/j.jaci.2018.05.026
   PubMed Web of Science ®Google Scholar
• Ostling J, van Geest M, Schofield JPR, et al. IL-17-high asthma with features of a psoriasis immunophenotype. J Allergy Clin Immunol. 2019;144(5):1198–1213. doi: 10.1016/j.jaci.2019.03.027
   PubMed Web of Science ®Google Scholar
• Badi YE, Pavel AB, Pavlidis S, et al. Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma. J Allergy Clin Immunol. 2022 Jan;149(1):89–101. doi: 10.1016/j.jaci.2021.04.010
   PubMed Web of Science ®Google Scholar
• Tiotiu A, Badi Y, Kermani NZ, et al. Association of differential mast cell activation with granulocytic inflammation in severe asthma. Am J Respir Crit Care Med. 2022 Feb 15;205(4):397–411. doi: 10.1164/rccm.202102-0355OC
   PubMed Web of Science ®Google Scholar
• Kelsen SG, Agache IO, Soong W, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial. J Allergy Clin Immunol. 2021 Apr 16;148(3):790–798. doi: 10.1016/j.jaci.2021.03.044
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Ruddy MK, Pavord ID, et al. Efficacy and safety of Itepekimab in patients with moderate-to-severe asthma. N Engl J Med. 2021 Oct 28;385(18):1656–1668. doi: 10.1056/NEJMoa2024257
   PubMed Web of Science ®Google Scholar
• Sánchez-Ovando S, Pavlidis S, Kermani NZ, et al. Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts. Respirology. 2022 Sep;27(9):730–738. doi: 10.1111/resp.14302
   PubMed Web of Science ®Google Scholar
• Tiotiu A, Zounemat Kermani N, Badi Y, et al. Sputum macrophage diversity and activation in asthma: role of severity and inflammatory phenotype. Allergy. 2021 Mar;76(3):775–788. doi: 10.1111/all.14535
   PubMed Web of Science ®Google Scholar